Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
19 April 2021 | Story NONSINDISO QWABE | Photo Supplied
LLB graduate Tshepang Mahlatsi

 
‘Be loyal to your calling and the universe will locate you.’ This slogan is the mantra that University of the Free State LLM student, Tshepang Mahlatsi, lives by. It is also this slogan that carried him through a tumultuous journey during the pursuit of his LLB degree, which he received during the Bloemfontein Campus graduation ceremony on 19 April. 

Mahlatsi began his LLB degree in 2014, but he had to take a break from his academics in 2016 after being clinically diagnosed with depression. He obtained his qualification in 2020. Mahlatsi said 2016 was a year that started on a high note for him as a third-year Law student and newly elected prime for Tswelopele residence, but quickly took a downward dive when he found himself overwhelmed by leadership demands – coupled with the simultaneous loss of loved ones and constant academic pressure. It ultimately led to a breakdown, forcing him to put his studies on hold. "I am graduating with my LLB after life-changing events in my undergraduate years – from student politics, depression, and PTSD, to starting a mental-health organisation and using both CUADS and Kovsie Counselling support services to come back to ‘normalcy’.”

He said the year-long break from his studies left him feeling discouraged as he watched his peers and classmates progress and graduate. "It was the most difficult thing to do to remind myself that I wasn't stupid." 

"This journey exposed a lot about myself; it exposed that with determination and resilience, you can achieve what you set out to achieve. I had to persevere not because I wanted to, but because my family has never seen a graduate. I was doing this for them; to give them something they've never had,” he said. 

UFS support services can save lives 

Mahlatsi would like more students to make use of the UFS support services and not crumble under mental-health problems. "I hope to inspire students to use their support services and not be ashamed – services such as CUADS and Student Counselling and Development. I hope to inspire student leaders and students to realise that you can be a well-rounded student and still have challenges, but eventually, success awaits us all."

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept